Reposted by Lidia Atencia Taboada
“GSK-3 and BCL-XL inhibition mitigates the competitive advantage of APC-mutant colorectal cancer cells”
🔷 Jan Paul Medema latest research is now available to read in #Oncogenesis.
▶️ Read the full open access article here: www.nature.com/articles/s41...